Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Phase 2

Completed

• Conditions: Opioid-Related Disorders; Substance-Related Disorders

• Registration Number: NCT00000319
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.

Detailed Description

Not available

Study Timeline

• Study Start: 1996-06
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Study Completion: 2005-01
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-03
• Last Update Posted: 2020-07-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Withdrawal symptoms
Social and psychological functioning
Opioid and cocaine use
AIDS risk behavior
Depression
Opiate withdrawal symptoms

Trial Locations

Locations (1)

APT Residential Services Division; 🇺🇸 New Haven, Connecticut, United States